Zaniolo O, Bamfi F, Iannazzo S. Budget impact of rosiglitazone in type 2 diabetes. Farmeconomia. Health Economics and Therapeutic Pathways. 2007;8(1):15-26. https://doi.org/10.7175/fe.v8i1.252